University of Toronto/Sunnybrook Research Institute
Collaborator: Dr. Elizabeth Asztalos, University of Toronto/Sunnybrook Research Institute
Health Categories: Immunity
Research Summary: Almost 3,000 very low birth weight (VLBW <1500g) preterm infants are born and treated in Canada annually. and aboutAbout 1,200 preterm infants either die, or survive with severe brain, or lung injury. This study aims to evaluate the role of oral bovine lactoferrin in reducing the rate of mortality, or major morbidity in VLBW preterm infants. This study is being carried out at multiple trial sites in Canada, New Zealand, Australia and the United States.
SF Summarization: This study aims to evaluate the role of oral bovine lactoferrin (a glycoprotein found in breast milk) in reducing the rate of mortality, or major morbidity, in very low birth weight preterm infants.
Current Status: Ongoing
Stage: Clinical study